(2R,3R)-1-[(tert-butoxy)carbonyl]-3-fluoropyrrolidine-2-carboxylic acid, 97%, 500mg

Bosutinib>95.0%(HPLC)(T)250mg

5-Bromo-7-methoxyquinoline, 97%, 100mg

5-cyclopropyl-N-(diaminomethylidene)-1-(quinolin-5-yl)-1H-pyrazole-4-carboxamide, 98%, 500mg

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 5g

5-Hexyl-2,2'-bithiophene, 95.0%, 250mg

5-(5-Fluoro-2-methyl-phenyl)-1H-tetrazole, 95.0%, 1g

2'-TRIFLUOROMETHOXYPHENYL ACETYLENE, 90.0%, 5g

Indole-3-carboxylic acid, 98.0%, 500g

1-Méthyl-3-octyl-imidazolium-, tétrafluoroborate >99%, 100 g, emballage verre

2-Phenylfuran, 95.0%, 250mg

Methyl tiglate, 25g

methyl 2-[(4-nitro-1H-pyrazol-1-yl)methyl]benzoate, 250mg